Mar 08, 2018 13:04 pm UTC| Business
CORAL GABLES, Fla., March 08, 2018 -- Catalyst Pharmaceuticals, Inc. (Nasdaq:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating, chronic...
Mar 08, 2018 13:04 pm UTC| Business
Press Release Fifth annual global competition provides the opportunity to present game-changing innovations to leaders in science, technology, engineering and mathematics Opportunity to collaborate with...
Mar 08, 2018 13:04 pm UTC| Business
NEW YORK, March 08, 2018 -- The global ceramic proppant market was growing at a progressive rate in 2017 and is expected to grow at a significant rate during the forecast period, growing at a CAGR of 13.2% from...
Mar 08, 2018 13:04 pm UTC| Business
WATERTOWN, Mass., March 08, 2018 -- Selecta Biosciences, Inc. (NASDAQ:SELB), a clinical-stage biopharmaceutical company focused on unlocking the full potential of biologic therapies by avoiding unwanted immune...
Mar 08, 2018 13:03 pm UTC| Business
SAN FRANCISCO, March 08, 2018 -- via OTC PR WIRE--Elto Pharma, Inc., a specialty pharmaceutical, clinical-stage wholly-owned subsidiary of Amarantus Bioscience Holdings, Inc. (OTCPK:AMBS), advancing Eltoprazine into a...
Metrospaces Issues March 2018 Shareholder Letter
Mar 08, 2018 13:03 pm UTC| Business
NEW YORK, NY, March 08, 2018 -- Metrospaces, Inc. (OTC PINK: MSPC) issues Letter to Shareholders to update on current events and progress. LETTER TO OUR SHAREHOLDERS To Metrospaces Inc. Shareholders: As we...
Mar 08, 2018 13:03 pm UTC| Business
AUSTIN, Texas, March 08, 2018 -- Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE), a clinical-stage biotechnology company that designs and develops innovative human enzyme therapeutics for patients with rare genetic diseases...